{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:28Z","timestamp":1787241928235,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Small intestinal neuroendocrine tumour (siNET) has distinct features and disease course compared to other gastrointestinal neuroendocrine tumours. While they mostly present with subtle symptoms, they also can present acutely requiring emergency surgical intervention. We assessed the impact of surgical intervention timing on oncological outcomes of siNET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective observational single centre cohort study of all patients diagnosed with siNET, and received surgical intervention at a tertiary level hospital between 2008 and 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 66 patients were diagnosed with SiNET. 22 patients were excluded due to incomplete data (9 patients) and not meeting the eligibility criteria (13 patients). Total of 44 patients met the inclusion criteria, with 30% underwent emergency resection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) and 70% underwent elective resection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931). Small bowel obstruction represented the most common cause for emergency presentations (61%), while incidental radiological findings (39%) and carcinoid syndrome (35%) accounted for most elective presentations. Emergency cases were associated with the absence of pre-operative somatostatin receptor imaging, less findings of mesenteric mass (31% vs. 81%), more likelihood of post operative macroscopic residual disease (46% vs. 23%) and disease specific mortality (75% vs. 23%). However, there was no statistically significant difference between the two groups in primary and secondary oncological outcomes. There were no operative or in-hospital mortality in either group as well as no significant difference in complications rates between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although emergency surgery was associated with limited preoperative staging and higher proportion of R2 resections, no statistically significant differences in overall survival, recurrence-free survival, carcinoid symptom resolution or local complications were observed. However, these results need to be interpreted cautiously due to the small sample size of the study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12029-026-01419-9","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:24:23Z","timestamp":1771475063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncological Outcomes after Elective and Emergency Resection of Small Intestinal Neuroendocrine Tumours"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1344-1296","authenticated-orcid":false,"given":"Ibrahim","family":"Alibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denna","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Tu","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-380X","authenticated-orcid":false,"given":"Ankit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-2401","authenticated-orcid":false,"given":"Desmond","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-089X","authenticated-orcid":false,"given":"Sivakumar","family":"Gananadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"5","key":"1419_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000481390","volume":"33","author":"G Kl\u00f6ppel","year":"2017","unstructured":"Kl\u00f6ppel G. Neuroendocrine neoplasms: Dichotomy, origin and classifications. Visc Med. 2017;33(5):324\u201330. https:\/\/doi.org\/10.1159\/000481390.","journal-title":"Visc Med"},{"key":"1419_CR2","doi-asserted-by":"publisher","unstructured":"Lamarca A, Bartsch DK, Caplin M, Kos-Kudla B, Kjaer A, Stefano, Partelli, et al. European neuroendocrine tumor society (ENETS) 2024 guidance paper for the management of well\u2010differentiated small intestine neuroendocrine tumours. J Neuroendocrinol. 2024;36(9). https:\/\/doi.org\/10.1111\/jne.13423.","DOI":"10.1111\/jne.13423"},{"key":"1419_CR3","doi-asserted-by":"publisher","unstructured":"Webster AP, Chrissie Thirlwell. The molecular biology of midgut neuroendocrine neoplasms. Endocr Rev. 2023;20. https:\/\/doi.org\/10.1210\/endrev\/bnad034.","DOI":"10.1210\/endrev\/bnad034"},{"issue":"18","key":"1419_CR4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the united States. J Clin Oncol. 2008;26(18):3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1419_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934\u201359. https:\/\/doi.org\/10.1002\/cncr.11105.","journal-title":"Cancer"},{"key":"1419_CR6","unstructured":"Malone JC. Abdul Basit Shah. Embryology, Midgut [Internet]. Nih.gov. StatPearls Publishing; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553156\/"},{"issue":"7","key":"1419_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844\u201360. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.304.","journal-title":"Ann Oncol"},{"issue":"6","key":"1419_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","volume":"36","author":"O Norl\u00e9n","year":"2012","unstructured":"Norl\u00e9n O, St\u00e5lberg P, \u00d6berg K, Eriksson J, Hedberg J, Hessman O, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg. 2012;36(6):1419\u201331. https:\/\/doi.org\/10.1007\/s00268-011-1296-z.","journal-title":"World J Surg"},{"issue":"1","key":"1419_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/PAS.0000000000000751","volume":"41","author":"CR Fata","year":"2017","unstructured":"Fata CR, Gonzalez RS, Liu E, Cates JM, Shi C. Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am J Surg Pathol. 2017;41(1):128\u201333. https:\/\/doi.org\/10.1097\/PAS.0000000000000751.","journal-title":"Am J Surg Pathol"},{"key":"1419_CR10","unstructured":"Vinik A, Hughes MS, Feliberti E, Perry RR, Casellini C, Sinesi M et al. Carcinoid Tumors [Internet]. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K., editors. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2000 [cited 2021 Mar 31]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279162\/"},{"issue":"6","key":"1419_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American neuroendocrine tumor society. Pancreas. 2017;46(6):715\u201331. https:\/\/doi.org\/10.1097\/MPA.0000000000000846.","journal-title":"Pancreas"},{"issue":"4","key":"1419_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1677\/ERC-10-0152","volume":"17","author":"MB Niederle","year":"2010","unstructured":"Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European neuroendocrine tumour society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010;17(4):909\u201318. https:\/\/doi.org\/10.1677\/ERC-10-0152.","journal-title":"Endocr Relat Cancer"},{"key":"1419_CR13","doi-asserted-by":"crossref","unstructured":"Alexandraki KI, Angelousi A, Eleftherios Chatzellis, Chrisoulidou A, Nikolaos Kalogeris, Kanakis G et al. The role of somatostatin analogues in the control of diarrhea and flushing as markers of carcinoid syndrome: a systematic review and meta-analysis. J Person Med [Internet]. 2023;13(2):304\u20134 [cited 2024 Aug 19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9959441\/\u200c","DOI":"10.3390\/jpm13020304"},{"issue":"10","key":"1419_CR14","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/000313481808401006","volume":"84","author":"N Manguso","year":"2018","unstructured":"Manguso N, Gangi A, Nissen N, Attiya Harit, Siegel E, Hendifar A, et al. Long-Term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors. Am Surg. 2018;84(10):1570\u20134. https:\/\/doi.org\/10.1177\/000313481808401006.","journal-title":"Am Surg"},{"key":"1419_CR15","doi-asserted-by":"publisher","first-page":"102197","DOI":"10.1016\/j.canep.2022.102197","volume":"79","author":"S Snorradottir","year":"2022","unstructured":"Snorradottir S, Asgeirsdottir A, R\u00f6gnvaldsson S, Jonasson J, ES Bj\u00f6rnsson. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study. Cancer Epidemiol. 2022;79:102197\u20137. https:\/\/doi.org\/10.1016\/j.canep.2022.102197.","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"1419_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.dld.2011.04.021","volume":"43","author":"C Le Roux","year":"2011","unstructured":"Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E, et al. Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study. Dig Liver Disease. 2011;43(10):828\u201333. https:\/\/doi.org\/10.1016\/j.dld.2011.04.021.","journal-title":"Dig Liver Disease"},{"issue":"4","key":"1419_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1457496924127184","volume":"113","author":"F Butz","year":"2024","unstructured":"Butz F, Supper L, Reinhard L, Dukaczewska A, Jann H, Fehrenbach U, M\u00fcller-Debus CF, Skachko T, Pratschke J, Goretzki PE, Mogl MT, Dobrindt EM. Emergency surgery influences oncological outcome in small intestinal neuroendocrine tumors. Scand J Surg. 2024;113(4):303\u201313. https:\/\/doi.org\/10.1177\/1457496924127184.","journal-title":"Scand J Surg"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01419-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:24:24Z","timestamp":1771475064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01419-9","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}